WC
ACAD icon

Wexford Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Wexford Capital’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,600
Closed -$351K – 142
2017
Q2 		$351K Buy
+12,600
New +$376K 0.03% 136
2016
Q4 		– Sell
-31,100
Closed -$989K – 250
2016
Q3 		$989K Buy
+31,100
New +$1.05M 0.16% 99
2015
Q4 		– Sell
-14,815
Closed -$490K – 63
2015
Q3 		$490K Hold
14,815
– – 0.09% 73
2015
Q2 		$620K Hold
14,815
– – 0.17% 51
2015
Q1 		$483K Buy
+14,815
New +$509K 0.14% 55
2014
Q2 		– Sell
-182,871
Closed -$4.45M – 113
2014
Q1 		$4.45M Buy
+182,871
New +$4.63M 0.34% 44

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return